
Diagnostic Imaging in Retinal Vascular Disease Management
In this episode, “Diagnostic Imaging in Retinal Vascular Disease Management,” the panelists explore how recent innovations in multimodal imaging are transforming the diagnosis and management of retinal vascular diseases, including AMD, diabetic macular edema (DME), diabetic retinopathy (DR), and retinal vein occlusion (RVO). The expert faculty discuss the growing role of optical coherence tomography (OCT) as the foundational imaging modality in retina clinics and how additional technologies such as fundus autofluorescence, OCT angiography (OCTA), and ultra-widefield imaging are expanding clinicians’ ability to detect and monitor disease activity.
Episodes in this series

In this episode, “Diagnostic Imaging in Retinal Vascular Disease Management,” the panelists explore how recent innovations in multimodal imaging are transforming the diagnosis and management of retinal vascular diseases, including AMD, diabetic macular edema (DME), diabetic retinopathy (DR), and retinal vein occlusion (RVO). The expert faculty discuss the growing role of optical coherence tomography (OCT) as the foundational imaging modality in retina clinics and how additional technologies such as fundus autofluorescence, OCT angiography (OCTA), and ultra-widefield imaging are expanding clinicians’ ability to detect and monitor disease activity.
Throughout the discussion, the panel highlights how OCTA has increasingly replaced traditional fluorescein angiography in many clinical settings, while ultra-widefield angiography continues to provide valuable insights into peripheral retinal pathology, particularly in patients with diabetic eye disease and ischemic vein occlusions. The panelists also discuss the growing adoption of OCT and widefield imaging technologies within general ophthalmology and optometry practices, leading to earlier referrals and earlier identification of retinal disease before significant vision loss occurs.
The panel further emphasizes the importance of imaging in guiding individualized patient management and improving long-term visual outcomes. In addition, the expert faculty discuss future opportunities for noninvasive imaging technologies and how continued advancements may further enhance disease detection, monitoring, and treatment decision-making across retinal vascular diseases.
The next episode in this series, “Treatment Goals in Retinal Vascular Diseases,” features the panelists discussing how evolving anti-VEGF treatment strategies are shaping long-term disease management across AMD, DME, DR, and RVO. The expert faculty highlight approaches to balancing visual outcomes, retinal fluid control, treatment durability, and patient burden in clinical practice.





















